文献速递湿疹皮炎与荨麻疹毛发、甲与色素性疾病

纳曲酮治疗慢性炎症性皮肤病的作用:系统综述

Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review.
PubMed 文献 · JAMA Dermatol · 2019-01-01

该系统综述检索1971年至2018年4月的文献,从1037篇文章中纳入22篇进行定性综合分析。结果显示,低剂量、高剂量及局部纳曲酮对多种病因所致瘙痒有效,低剂量纳曲酮对Hailey-Hailey病和毛发扁平苔藓安全有效,高剂量不良反应更多,仍需进一步证据确定剂量和长期治疗指南。

要点

  • 低剂量纳曲酮对Hailey-Hailey病和毛发扁平苔藓安全有效。
  • 低剂量和高剂量纳曲酮均可成功治疗多种病理状况所致瘙痒。
  • 高剂量纳曲酮不良反应更多,剂量和长期治疗指南仍需更多证据。

核心结论

  • 低剂量纳曲酮对Hailey-Hailey病和毛发扁平苔藓安全有效,低剂量和高剂量纳曲酮均可成功治疗多种病理状况所致瘙痒,但高剂量不良反应更多。
  • 低剂量纳曲酮有潜力治疗慢性炎症性皮肤病,但剂量和长期治疗指南仍需更多证据。

研究设计与样本

  • 系统综述,检索PubMed 1971年至2018年4月发表的文章,检索词为纳曲酮或低剂量纳曲酮与皮肤病学或皮肤或毛发或指甲,排除综述、动物研究及非皮肤病学和药理学研究。
  • 从1037篇文章中纳入22篇进行定性综合分析,包括随机临床试验、病例报告和系列病例。
  • 22篇文章中7篇关于低剂量纳曲酮,1篇关于局部纳曲酮,14篇关于高剂量纳曲酮在皮肤病学中的应用。

主要发现

  • 高剂量、低剂量和局部纳曲酮对特应性皮炎、结节性痒疹、胆汁淤积、烧伤、系统性硬化症、Hailey-Hailey病和毛发扁平苔藓所致瘙痒有效。
  • 高剂量纳曲酮对潮红和尿毒症性瘙痒无效,很可能因为这些疾病的病理生理机制缺乏阿片类药物参与。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Dermatology is encountering increasing rates of autoimmune disease manifesting in primary skin conditions that are difficult to treat without a risk of immunosuppression. Naltrexone is an orally active opioid antagonist that influences a variety of systemic pathways, including the immune system, in low doses of 1.5 to 4.0 mg/d. This phenomenon has piqued the interest of researchers and practitioners in regard to low-dose naltrexone's potential in the treatment of several autoimmune conditions. OBJECTIVE: To review the existing literature on naltrexone treatment for dermatologic conditions. EVIDENCE REVIEW: A primary literature search was conducted using PubMed in April 2018 for all articles published from 1971 to April 2018. Search terms consisted of naltrexone or low dose naltrexone or low-dose naltrexone and dermatology or skin or hair or nails. Reviews, animal studies, and nondermatologic and pharmacologic studies were excluded. FINDINGS: From 1037 articles, 22 were deemed to be appropriate for inclusion in this review for a qualitative synthesis. The 22 articles included randomized clinical trials, case reports, and series. There were 7 articles on low-dose naltexone, 1 on topical naltrexone, and 14 on high-dose naltrexone use in dermatology. In high, low, and topical doses, naltrexone was effective in treating pruritus attributable to atopic dermatitis, prurigo nodularis, cholestatsis, burn injury, systemic sclerosis, Hailey-Hailey disease, and lichen planopilaris. High-dose naltrexone was ineffective in treating flushing and uremic pruritus most likely because of the lack of opioid involvement in the pathophysiologic mechanisms of these conditions. CONCLUSIONS AND RELEVANCE: The findings suggest that low-dose naltrexone is safe and effective in the treatment of Hailey-Hailey disease and lichen planopilaris and both low- and high-dose naltrexone successfully treat pruritus attributable to various pathologic conditions; however, more adverse effects occurred in those taking high doses. Low-dose naltrexone has the potential for the treatment of chronic inflammatory skin conditions; however, additional evidence is needed for dosing and long-term treatment guidelines.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Ekelem C, Juhasz M, Khera P, et al. Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review. JAMA Dermatol. 2019. PMID: 30484835. doi:10.1001/jamadermatol.2018.4093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。